Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy. (Q33801908)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A Jenei

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Damjanovich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T M Jovin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Szölôsi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

Pathology Oncology Research

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

255-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Colocalization of the p185HER2 oncoprotein and integrin alpha 6 beta 4 in Calu-3 lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Growth factor modulation of p53-mediated growth arrest versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

A unified model of c-erbB receptor homo- and heterodimerisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Structural hierarchy in the clustering of HLA class I molecules in the plasma membrane of human lymphoblastoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

The p185erbB2 protein is localized on cell organelles involved in cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Lipid microdomains in cell surface membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Dimerization of cell surface receptors in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Domains in cell plasma membranes investigated by near-field scanning optical microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Recombinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Two EGF molecules contribute additively to stabilization of the EGFR dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Regulation of signal transduction and signal diversity by receptor oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Herceptin raises its sights beyond advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Multiple essential functions of neuregulin in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Development of anti-p185HER2 immunoliposomes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Severe neuropathies in mice with targeted mutations in the ErbB3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Functional rafts in cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Bivalence of EGF-like ligands drives the ErbB signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Alternative intracellular routing of ErbB receptors may determine signaling potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

ErbB-2 amplification inhibits down-regulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Regulation of cellular response to cisplatin-induced DNA damage and DNA repair in cells overexpressing p185(erbB-2) is dependent on the ras signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

Rotational mobility of high-affinity epidermal growth factor receptors on the surface of living A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FPAOR.1999.0255

C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer

21 January 2018

1 reference

12 December 2020

Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts

1 reference

12 December 2020

Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.

1 reference

12 December 2020

Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth

1 reference

12 December 2020

Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells

1 reference

12 December 2020

Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells

1 reference

12 December 2020

Secondary dimerization between members of the epidermal growth factor receptor family

1 reference

12 December 2020

Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation

1 reference

12 December 2020

Modulation of epidermal growth factor receptor interaction with the detergent-insoluble cytoskeleton and its effects on receptor tyrosine kinase activity

1 reference

12 December 2020

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

12 December 2020

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

1 reference

12 December 2020

Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells

1 reference

12 December 2020

HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications

1 reference

12 December 2020

A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors

1 reference

12 December 2020

The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity

1 reference

12 December 2020

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

12 December 2020

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

12 December 2020

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

1 reference

12 December 2020

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

1 reference

12 December 2020

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

1 reference

12 December 2020

The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor

1 reference

12 December 2020

Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor

1 reference

12 December 2020

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

12 December 2020

Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts

1 reference

12 December 2020

Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors

1 reference

12 December 2020

Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha

1 reference

12 December 2020

Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction

1 reference

12 December 2020

The erbB3 gene product is a receptor for heregulin

1 reference

12 December 2020

A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells

1 reference

12 December 2020

Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification

1 reference

12 December 2020

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

12 December 2020

c-erbB-2 amplification in mammary carcinoma

1 reference

12 December 2020

Domain-specific Interactions between the p185neuand Epidermal Growth Factor Receptor Kinases Determine Differential Signaling Outcomes

1 reference

12 December 2020

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin

1 reference

12 December 2020

p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.

1 reference

12 December 2020

Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2

1 reference

12 December 2020

Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice

1 reference

12 December 2020

Kinetic concepts in the systemic drug therapy of breast cancer

1 reference

12 December 2020

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens

1 reference

12 December 2020

Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-2-positive malignant cell lines

1 reference

12 December 2020

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

1 reference

12 December 2020

Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody

1 reference

12 December 2020

The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

12 December 2020

Biomarkers in early breast neoplasia

1 reference

12 December 2020

Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy

1 reference

12 December 2020

Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway

1 reference

12 December 2020

Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells

1 reference

12 December 2020

Prognostic impact of tumor biological factors on survival in node-negative breast cancer

1 reference

12 December 2020

Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms

1 reference

12 December 2020

ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

1 reference

12 December 2020

c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study

1 reference

12 December 2020

Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells

1 reference

12 December 2020

Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins

1 reference

12 December 2020

Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product

1 reference

12 December 2020

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

1 reference

12 December 2020

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

12 December 2020

Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.

1 reference

12 December 2020

Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells.

1 reference

12 December 2020

HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis

1 reference

12 December 2020

Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities

1 reference

12 December 2020

Endocytosed epidermal growth factor (EGF) receptors contribute to the EGF-mediated growth arrest in A431 cells by inducing a sustained increase in p21/CIP1

1 reference

12 December 2020

Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase

1 reference

12 December 2020

Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.

1 reference

12 December 2020

Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225

1 reference

12 December 2020

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

1 reference

12 December 2020

Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells.

1 reference

12 December 2020

Microaggregation of hormone-occupied epidermal growth factor receptors on plasma membrane preparations

1 reference

12 December 2020

Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland

1 reference

12 December 2020

Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY

1 reference

12 December 2020

Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas

1 reference

12 December 2020

ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer

1 reference

12 December 2020

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers

1 reference

12 December 2020

A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells

1 reference

12 December 2020

c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy

1 reference

12 December 2020

Identifiers

DOI

10.1053/PAOR.1999.0255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10607920%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 November 2019

1040856892

0 references

1 reference